|
Various Medicinal Products - Delivery Of Drugs, Pharmaceutical Preparations, Hemostatic Preparations, Immunoglobulins, Oncological Drugs, Contrasts, Disinfectants And Others For A Period Of 24 Months - Drug Program.. Part 1 - Cytotosic Drugs In Injection Form (With The Possibility Of Using In A Drug Program),Part 2 - Crisantaspase (With The Possibility Of Using In A Drug Program),Part 3 - Inotuzumab Ozogamicin (With The Possibility Of Using In A Drug Program),Part 4 - Brentuximabum Vedotin (With The Possibility Of Using In A Drug Program),Part 5 - Cytotosic Drugs In Injection Form (With The Possibility Of Using In A Drug Program),Part 6 - Different Medications (With The Possibility Of Using In The Drug Program),Part 7 - Blinatumomabum (With The Possibility Of Using In A Drug Program),Part 8 Oncological Drugs - Oral Form (With The Possibility Of Use In A Drug Program),Part 9- Rituximab (With The Possibility Of Using In A Drug Program),Part 10- Oncological Drugs - Injection Form (With The Possibility Of Use In The Drug Program),Part 11- Oncological Drugs Oral Form (With The Possibility Of Use In The Drug Program),Part 12- Pegasparaginase (With The Possibility Of Using In The Drug Program),Part 13- Pembrolyzumabum (With The Possibility Of Using In A Drug Program),Part 14- Oncological Drugs - Oral Form (With The Possibility Of Use In A Drug Program),Part 15- Various Drugs (With The Possibility Of Use In The Drug Program),Part 16- Tocilizumabum (With The Possibility Of Using In A Drug Program),Part 17- Various Drugs (With The Possibility Of Use In The Drug Program),Part 18- Monoclonal Antibodies, Which Are Used In Unstable Ischemic Heart Disease (With The Possibility Of Use In The Drug Program),Part 19 - Different Medications (With The Possibility Of Use In The Drug Program),Part 20 - Interferon (With The Possibility Of Using In The Drug Program),Part 21 - Different Drugs (With The Possibility Of Use In The Drug Program),Part 22 - Room Medicines (With The Possibility Of Using In The Drug Program),Part 23 - Letermovir (With The Possibility Of Using In A Drug Program),Part 24 - Ekulizumabum (With The Possibility Of Using In A Drug Program),Part 25 - Guselkumabum (With The Possibility Of Use In The Drug Program),Part 26 - Risankizazumabum (With The Possibility Of Using In A Drug Program),Part 27 - Romiplostimum (With The Possibility Of Using In A Drug Program),Part 28 - Eltombopag (With The Possibility Of Using In A Drug Program),Part 29 - Clostridum Botulineum Type A Toxin (With The Possibility Of Using In The Drug Program),Part 30 - Cinacalcet (With The Possibility Of Using In A Drug Program),Part 31 - Darboteetinum Alfa (With The Possibility Of Using In A Drug Program),Part 32 - Adalimumab (With The Possibility Of Using In A Drug Program),Part 33 - Aflibercept (With The Possibility Of Using In A Drug Program),Part 34 - Infliximabum (With The Possibility Of Using In A Drug Program),Part 35 - Glatiramer Acetate (With The Possibility Of Using In A Drug Program),Part 36 - Pasireotidum (With The Possibility Of Using In A Drug Program),Part 37 - Secukinumabum (With The Possibility Of Using In A Drug Program),Part 38 - Ranibizumabum (With The Possibility Of Using In A Drug Program),Part 39 - Lanreotidum Autogel (With The Possibility Of Using In The Drug Program),Part 40 - Octreotide (With The Possibility Of Using In A Drug Program),Part 41 - Paricalcitulum (With The Possibility Of Using In A Drug Program),Part 42 - Ixeskizumabum (With The Possibility Of Using In The Drug Program),Part 43 - Ustcinumabum (With The Possibility Of Using In A Drug Program),Part 44 - P
|
